HTA86 Establishing the Multi-Criteria Decision Analysis (MCDA) Framework to Assess the Value of Orphan Drugs in China: From the Perspective of Stakeholders and the Public
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1515
https://www.valueinhealthjournal.com/article/S1098-3015(23)01615-7/fulltext
Title :
HTA86 Establishing the Multi-Criteria Decision Analysis (MCDA) Framework to Assess the Value of Orphan Drugs in China: From the Perspective of Stakeholders and the Public
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01615-7&doi=10.1016/j.jval.2023.03.1515
First page :
Section Title :
Open access? :
No
Section Order :
10914